Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06395168 · ClinicalTrials.gov registry record · NA
Mayo Clinic Health System Northwest Wisconsin Integrated Maternal Postpartum Appointment Combination
A NA study of Breastfeeding, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 246
- Enrollment target
- 1
- Study location
NCT06395168: Recruiting NA study of Breastfeeding, sponsored by Mayo Clinic.
NCT06395168 is a NA study of Breastfeeding that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 246 participants, below the 590-participant average among 36 other Breastfeeding trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06395168, a NA study of Breastfeeding, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 246 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to explore whether combining the first post-hospital newborn provider visit and lactation consultation into a single appointment can enhance rates of successful breastfeeding initiation and continuation at predefined intervals (e.g., one week, one month, two months, three months, four months, six months, and 12 months postpartum).
Primary Outcome
Looking for the difference of breastfeeding continuation between the intervention and control group. Hypothesis is higher breastfeeding rates in the combined lactation/newborn visit.
Conditions Studied
Interventions
- OTHER Combined Newborn and Lactation Visit
Study Locations (1)
Wisconsin
- Mayo Clinic Health System-Eau Claire Clinic - Eau Claire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 246 participants |
| Start Date | 2024-08-19 |
| Est. Completion | 2026-10 |
| Phase | NA |
What NCT06395168 shows while recruiting
NCT06395168 is an interventional study that assigns participants to a tested intervention. The registered 246 participants enrollment target is mid-sized for trials with a published cap, below the 590-participant average among 36 other Breastfeeding trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Breastfeeding appearing as the primary indexed condition, and to 1 intervention - of which Combined Newborn and Lactation Visit is the first listed.
NCT06395168 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06395168 about?
NCT06395168 is a clinical study titled "Mayo Clinic Health System Northwest Wisconsin Integrated Maternal Postpartum Appointment Combination". The purpose of this study is to explore whether combining the first post-hospital newborn provider visit and lactation consultation into a single appointment can enhance rates of successful breastfeeding initiation and continuation at predefined intervals (e.g., one week, one month, two months, thre...
What is the current status of trial NCT06395168?
This trial is currently recruiting. It is a NA study. The enrollment target is 246 participants. The study started on 2024-08-19. Estimated completion is 2026-10.
What conditions does trial NCT06395168 study?
This clinical trial studies the following conditions: Breastfeeding.
What interventions are being tested in trial NCT06395168?
The interventions under investigation include: Combined Newborn and Lactation Visit (OTHER).
Who is sponsoring clinical trial NCT06395168?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06395168 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breastfeeding
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06395168's enrollment target sits among peer trials
246 14th of 36 higher than 23 of 36 other Breastfeeding trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breastfeeding trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Furthering Equity Through Infant Feeding EDucation and Support
RECRUITING · NA
-
Support Via Online Social Networks to Promote Safe Infant Care Practices
RECRUITING · NA
-
Postnatal Exercise to Activate Baby's Brown Fat
RECRUITING · NA
-
Effect of Prenatal and Postnatal Intervention Strategies on Breastfeeding Outcomes in Women With Excessive Weight (Ready, Set, Nourish Study)
RECRUITING · NA
-
Development of the Couplet Care Bassinet
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04973605 · 246 participants · Phase 1
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
- NCT07048769 · 246 participants · Phase 4
Paracervical Block for Pain Reduction in Saline Infusion Sonograms
- NCT07176650 · 246 participants · Phase 1
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
- NCT04269902 · 247 participants · Phase 3
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI